Michelle Habets studies responsible innovation in biotechnology. Currently, she focuses on genome editing, cellular engineering and the T-TRIPP-project.
Education and career
Michelle studied biology and philosophy at the Radboud University Nijmegen. In 2008, she completed her PhD at the Lab of Genetics at Wageningen University. Her dissertation focused on the evolution of microbial diversity. From 2007 until 2011, she worked as a postdoctoral research associate at the University of Liverpool studying the risks of the use of antimicrobial peptides in health care. She subsequently obtained an MA in Healthcare Ethics and Law at the University of Manchester. In 2016, she finished her PhD at the University Medical Center Utrecht on the ethics of translational pluripotent stem cell research. At the Erasmus University Rotterdam, she worked on a project combining empirical research and expertise of health care and law to better understand and regulate end of life policies.
- Associate-PI of the BaSyC consortium.
- Member of the Ethics and Health committee at ZonMw, The Netherlands Organisation for Health Research and Development.
- Member of the COVID-19 committee at ZonMw.